all report title image

ENDOMETRIAL BIOPSY CANNULAE MARKET ANALYSIS

Endometrial Biopsy Cannulae Market by Product Type (Rigid Endometrial Biopsy Cannulae and Flexible Endometrial Biopsy Cannulae), by End User (Hospitals, Diagnostic Centers, Specialty Clinics, and Others) and by Region - Size, Share, Outlook and Opportunity Analysis, 2022-2028

  • To Be Published : Nov 2024
  • Code : CMI1937
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Endometrial Biopsy Cannulae MarketSize and Trends

Disease detection based on biopsy is gaining significant traction, owing to its accuracy, which is expected to drivie the endometrial biopsy cannulae market growth over the forecast period. For instance, according to National Cancer Institute, around 85% of endometrial cancer are diagnosed at earlier stage using endometrial sampling or biopsy. Moreover, increasing incidences of uterine related diseases are driving growth of the endometrial biopsy cannulae market.

Increasing incidences of uterine cancer is the major factor propelling demand for endometrial biopsy cannulae, which in turn is driving growth of the endometrial biopsy cannulae market size. For instance, according to National Cancer Institute’s Surveillance, Epidemiology, and End Results Program, an estimated new cases of cancer to be reported in 2018 are 63,230, in the U.S., which comprises 26.0 cases per 100,000 women.

Furthermore, same source reported an estimated 2.9% of women are expected to have uterine cancer during their lifespan. Therefore, population at high risk of developing cancer frequently undergo cancer diagnosis, which is propelling demand for endometrial biopsy cannulae. According to American Cancer Society’s (ACS) publication, Cancer Facts & Figures 2018, around 92% of uterine cancer are observed in endometrial lining and high prevalence of obesity increases the risk of uterine cancer development proportionally.

Infertility is also diagnosed using biopsy and high prevalence of infertility related issues are also expected to fuel growth of the endometrial biopsy cannulae market over the forecast period. For instance, according to Maternal Health Task Force (MHTF), a project of the Women and Health Initiative at the Harvard T.H. Chan School of Public Health, 2017, nearly 50 million couples experience infertility, worldwide.

Abnormal uterine bleeding is also a significant clinical condition demanding for endometrial biopsy. According to Best Practice & Research. Clinical Obstetrics & Gynaecology, 2016, heavy menstrual bleeding affects 14-25% of women of the reproductive age. Moreover, it states that 800,000 women consult medical professional for abnormal uterine bleeding annually.

Increasing initiatives to create awareness among population for early detection of diseases such as cancer and its importance to reduce the morbidity are expected to boost the endometrial biopsy cannulae market. For instance, governments and non-governmental organizations organize programs to spread awareness about early detection of cancer and its importance and also recommend for the periodic check-ups for cancer. Furthermore, consultation with respect to infertility are increasing at fast pace, owing to increasing awareness, which in turn is propelling the market growth.

Endometritis, uterine infection, is another common condition in the low income economies, which demands for clinical attention. For instance, according to Clinical and Experimental Reproductive Medicine, 2016, the prevalence of chronic endometritis is around 10% of the population.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.